10.17.19

Sleep Apnea Linked to Blinding Eye Disease in People with Diabetes

Source: American Academy of Ophthalmology

10.12.19

Kodiak Sciences Announces Data from Ongoing Phase 1b Study of KSI-301 in Patients With Wet AMD, DME and RVO

Source: Kodiak Sciences

10.09.19

Oxurion NV to Provide Business and Clinical Update at AAO and OIS Meetings in San Francisco

Source: Oxurion NV

10.08.19

Genentech/Roche Complete Enrollment in YOSEMITE and RHINE Phase 3 Studies of Faricimab in DME

Source: Genentech

09.19.19

Graybug Vision Initiates Clinical Trial in Macular Edema Secondary to DME or RVO

Source: Graybug Vision

09.12.19

Alimera Announces Expansion of Agreement with Distribution Partner Horus Pharma to Include Marketing Iluvien in Benelux Countries

Source: Alimera Sciences

09.10.19

Oxurion Reports Additional Positive Topline Data from Phase 1 With THR-149, a Novel, Potent Plasma Kallikrein Inhibitor for DME

Source: Oxurion NV

09.03.19

Oxurion to Make a Late-Breaker Presentation of Topline THR-149 Phase 1 Clinical Data at EURETINA

Source: Oxurion

08.20.19

Oxurion Reports Topline Month 3 Results of Phase 2a Study Evaluating THR-317 in Combination with Ranibizumab for DME

Source: Oxurion NV

08.20.19

Aerie Pharmaceuticals Initiates First-in-Human Clinical Trial of AR-13503 Sustained Release Intravitreal Implant in Patients with Wet AMD and DME

Source: Aerie Pharmaceuticals

View more stories